Top compounds associated with response to PDILT


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0094 0.8
mRNA nintedanib CTRPv2 pan-cancer AAC -0.0097 0.8
mRNA PL-DI CTRPv2 pan-cancer AAC 0.0081 0.8
mRNA XL-184 GDSC1000 pan-cancer AAC 0.0086 0.8
mRNA HBX-41108 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC -0.0078 0.8
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0092 0.8
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.0079 0.8
mRNA YM201636 GDSC1000 pan-cancer AAC 0.0075 0.8
mRNA MK-0752 CTRPv2 pan-cancer AAC -0.0093 0.8
Download CSV